List of works - Osvaldo Martinez

A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.

scientific article published on 9 January 2013

Characterization of a recombinant Yersinia enterocolitica lipoprotein; implications for its role in autoimmune response against thyrotropin receptor.

scientific article published on September 2004

Contrasting effects of IG20 and its splice isoforms, MADD and DENN-SV, on tumor necrosis factor alpha-induced apoptosis and activation of caspase-8 and -3

scientific article

Correlation of disease evolution with progressive inflammatory cell activation and migration in the IL-4 transgenic mouse model of atopic dermatitis

scientific article published on 01 February 2005

Corrigendum: Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors

scientific article published in Nature

DC-SIGN, but not sDC-SIGN, can modulate IL-2 production from PMA- and anti-CD3-stimulated primary human CD4 T cells

scientific article published on 8 June 2005

Diversity in the complementarity-determining region 3 (CDR3) of antibodies from mice with evolving anti-thyroid-stimulating hormone receptor antibody responses.

scientific article published on 26 October 2006

Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model

scientific article published on 01 December 2004

Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation

scientific article

Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.

scientific article

Ebola virus exploits a monocyte differentiation program to promote its entry

scientific article published on 23 January 2013

Ebola virus failure to stimulate plasmacytoid dendritic cell interferon responses correlates with impaired cellular entry.

scientific article

Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain.

scientific article published on 16 April 2007

Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells

scientific article published on 25 January 2011

Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse

scientific article published on 11 December 2006

IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC

scientific article

IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs

scientific article (publication date: 5 February 2004)

Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles.

scientific article

Influenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses

scientific article

Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus

scientific article (publication date: 15 January 2010)

Nanodisc-incorporated hemagglutinin provides protective immunity against influenza virus infection

scientific article

Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery.

scientific article

Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.

scientific article

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

scientific article

Targeted Delivery of Anti-CTLA-4 Antibody Downregulates T Cell Function in Vitro and in Vivo ⬇️

scientific article published on November 1, 2001

The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge

scientific article published on 8 February 2012

Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus

scientific article

Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition.

scientific article published on 22 September 2009

List of works by Osvaldo Martinez

A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.

Characterization of a recombinant Yersinia enterocolitica lipoprotein; implications for its role in autoimmune response against thyrotropin receptor.

Contrasting effects of IG20 and its splice isoforms, MADD and DENN-SV, on tumor necrosis factor alpha-induced apoptosis and activation of caspase-8 and -3

Correlation of disease evolution with progressive inflammatory cell activation and migration in the IL-4 transgenic mouse model of atopic dermatitis

Corrigendum: Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors

DC-SIGN, but not sDC-SIGN, can modulate IL-2 production from PMA- and anti-CD3-stimulated primary human CD4 T cells

Diversity in the complementarity-determining region 3 (CDR3) of antibodies from mice with evolving anti-thyroid-stimulating hormone receptor antibody responses.

Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model

Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation

Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.

Ebola virus exploits a monocyte differentiation program to promote its entry

Ebola virus failure to stimulate plasmacytoid dendritic cell interferon responses correlates with impaired cellular entry.

Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain.

Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells

Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse

IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC

IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs

Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles.

Influenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses

Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus

Nanodisc-incorporated hemagglutinin provides protective immunity against influenza virus infection

Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery.

Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

Targeted Delivery of Anti-CTLA-4 Antibody Downregulates T Cell Function in Vitro and in Vivo ⬇️

The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge

Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus

Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition.